Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1
- 1 April 1998
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 5 (3) , 271-278
- https://doi.org/10.1007/bf02303785
Abstract
Background: Breast tumors contain high numbers of infiltrating macrophages. The role and function of these cells within the tumor remain unclear, but a number of studies have found an association between poor prognosis and macrophage content in human breast cancer. Both hypoxia and TGFβ-1 have been shown to regulate VEGF in other cell types. We hypothesized that breast tumor-associated macrophages produce VEGF and that macrophage production of this factor is regulated by both hypoxia and TGFβ-1. Methods: Paraffin-embedded breast tumor sections were stained immunohistochemically with anti-VEGF, anti-CD68, and anti-cytokeratin. Monocytes were matured for 3 days in 20% autologous plasma and activated with 1000 U/mL interferon-γ for 24 hours. Supernatants were assayed for VEGF protein by ELISA. Total RNA was isolated from cells and reverse transcribed to cDNA, which was used as a template in PCR reactions for VEGF and β-actin. Results: Both tumor cells and tumor macrophages produce VEGF in human breast tumors. Hypoxia increases VEGF protein and mRNA levels in monocyte-derived macrophages, whereas TGFβ-1 increases VEGF protein but not mRNA under hypoxic growth conditions. Conclusions: Breast tumor-associated macrophages may contribute to the angiogenic activity of human breast tumors by producing VEGF. Macrophage production of VEGF is upregulated by hypoxia and TGFβ-1, both of which occur in the tumor environment. Macrophage production of VEGF is regulated at both the mRNA and protein levels.Keywords
This publication has 20 references indexed in Scilit:
- Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patientsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Secretion of epidermal growth factor by macrophages associated with breast carcinomaThe Lancet, 1993
- Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.The Journal of Experimental Medicine, 1992
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Solid tumours and wounds: transformed cells misunderstood as injured tissue?The Lancet, 1990
- Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.The Journal of Experimental Medicine, 1990
- A high macrophage content in human breast cancer is not associated with favourable prognostic factorsBritish Journal of Surgery, 1984
- Oxygen Tension Regulates the Expression of Angiogenesis Factor by MacrophagesScience, 1983
- Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites FluidScience, 1983
- TUMOR DORMANCY IN VIVO BY PREVENTION OF NEOVASCULARIZATIONThe Journal of Experimental Medicine, 1972